Efficacy, Safety and Dosage of Afatinib in Patients with NSCLC after Failure of Prior EGFR-TKI

被引：0
|
作者：
Kim, Young-Chul [1 ]
Choi, Hayoung [1 ]
Park, Cheol-Kyu [1 ]
Oh, In-Jae [1 ]
Yun, Ju-Sik [1 ]
Song, Sang-Yun [1 ]
Na, Kook-Joo [1 ]
Ahn, Sung-Ja [1 ]
Yoon, Mee Sun [1 ]
Choi, Yoo-Duk [1 ]
Seon, Hyun-Ju [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, Jeonnam, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Dose; afatinib; EGFR-TKI; EGFR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-015
引用
收藏
页码：S647 / S647
页数：1
相关论文
共 50 条
  • [1] Analysis of Efficacy and Safety of First Generation EGFR-TKI plus Apatinib in Treating Advanced NSCLC after EGFR-TKI Treatment Failure
    Feng, Y.
    Zhu, H.
    Hu, X.
    Liu, Y.
    Xing, P.
    Wang, H.
    Ji, X.
    Dai, Z.
    Shi, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S609 - S609
  • [2] Efficacy, Safety And Dosage Of Afatinib In Patients With Non-Small Cell Lung Cancer After Failure Of Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-Tki)
    Park, C.
    Kim, T.
    Shin, H.
    Ban, H.
    Lim, J.
    Kwon, Y.
    Oh, I.
    Kim, Y.
    Lim, S.
    Kim, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI
    Riess, J.
    Kelly, K.
    Schalper, K.
    Shimoda, M.
    Lim, S.
    Monjazeb, A.
    Danenberg, K.
    Moore, E.
    Beckett, L.
    Mack, P.
    Maverakis, E.
    Gandara, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S528 - S528
  • [4] The effectiveness of afatinib, a second-generation EGFR-TKI, for NSCLC patients in clinical practice
    Ohba, Taro
    Toyozawa, Ryo
    Nosaki, Kaname
    Umeyama, Yasuhiro
    Takamori, Shinkichi
    Haratake, Naoki
    Miura, Naoko
    Yamaguchi, Masafumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    [J]. CANCER SCIENCE, 2018, 109 : 1427 - 1427
  • [5] Efficacy and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced NSCLC Harboring Sensitive EGFR Mutations
    Yamada, Y.
    Imai, H.
    Minemura, H.
    Sugiyama, T.
    Kaira, K.
    Kanazawa, K.
    Kasai, T.
    Minato, K.
    Kaburagi, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S943 - S943
  • [6] Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
    Wang, Wenxian
    Wang, Hong
    Lu, Peihua
    Yu, Zongyang
    Xu, Chunwei
    Zhuang, Wu
    Song, Zhengbo
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [7] Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
    Wenxian Wang
    Hong Wang
    Peihua Lu
    Zongyang Yu
    Chunwei Xu
    Wu Zhuang
    Zhengbo Song
    [J]. Journal of Translational Medicine, 17
  • [8] Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment
    Furuta, Hiromi
    Uemura, Takehiro
    Yoshida, Tatsuya
    Kobara, Makiko
    Yamaguchi, Teppei
    Watanabe, Naohiro
    Shimizu, Junichi
    Horio, Yoshitsugu
    Kuroda, Hiroaki
    Sakao, Yukinori
    Yatabe, Yasushi
    Hida, Toyoaki
    [J]. ANTICANCER RESEARCH, 2018, 38 (09) : 5231 - 5237
  • [9] Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
    Takahashi, K.
    Ito, K.
    Murotani, K.
    Asada, K.
    Okuno, M.
    Kimura, T.
    Kubo, A.
    Suda, T.
    Taniguchi, H.
    Hataji, O.
    Shindo, J.
    Kunii, E.
    Yoshida, T.
    Imaizumi, K.
    Hida, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S833 - S833
  • [10] Efficacy and Safety of Cytotoxic Drug Chemotherapy After First-Line EGFR-TKI in Elderly Patients with NSCLC Harboring Sensitive EGFR Mutations
    Yamada, Y.
    Imai, H.
    Sugiyama, T.
    Minemura, H.
    Kaira, K.
    Kanazawa, K.
    Kasai, T.
    Kaburagi, T.
    Minato, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S908 - S908
12345